论文部分内容阅读
目的:探讨核苷类似物治疗慢性乙型肝炎(慢性乙肝)常见不规范用药的原因分析及对策。方法:2012年5月-2013年5月收治慢性乙肝患者240例,回顾性分析其临床资料,对不规范用药患者进行原因分析并提出相关对策。结果:年龄、病程、经济收入、文化程度、药物不良反应、慢性乙型肝炎相关知识都会影响规范用药。结论:慢性乙型肝炎患者进行核苷类药物治疗过程中存在一定程度的用药不规范,其影响因素复杂,应实施相应措施以提高治疗效果。
Objective: To investigate the causes and countermeasures of nucleoside analogue treatment of common non-standard drugs in chronic hepatitis B (chronic hepatitis B). Methods: From May 2012 to May 2013, 240 patients with chronic hepatitis B were admitted to our hospital. The clinical data were retrospectively analyzed. The causes of non-standard medication were analyzed and relevant countermeasures were proposed. Results: Age, duration of illness, economic income, educational level, adverse drug reactions and chronic hepatitis B related knowledge all influenced the standard medication. Conclusion: There is a certain degree of non-standard medication in patients with chronic hepatitis B during the treatment of nucleoside drugs. The influencing factors are complex and corresponding measures should be taken to improve the therapeutic effect.